Solara Active Pharma Sciences Publishes Newspaper Ads for Second and Final Call Notice

1 min read     Updated on 08 Apr 2026, 09:50 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Solara Active Pharma Sciences published newspaper advertisements on April 08, 2026, informing shareholders about the Second and Final Call Money Notice for partly paid-up rights equity shares. The advertisements in Business Standard and Pratahkal supplement the earlier electronic and physical notice dispatch, with shareholders required to pay ₹112.50 per share by May 07, 2026.

powered bylight_fuzz_icon
37168543

*this image is generated using AI for illustrative purposes only.

Solara Active Pharma Sciences Limited has published newspaper advertisements regarding the Second and Final Call Money Notice to holders of partly paid-up rights equity shares, following the earlier dispatch of notices to eligible shareholders. The company announced this development through regulatory filings on April 08, 2026.

Newspaper Publication Details

The pharmaceutical company published advertisements in leading newspapers on April 08, 2026, to inform shareholders about the circulation of the Second and Final Call Notice. The advertisements appeared in Business Standard and Pratahkal, providing wider visibility to the call money requirements.

Publication Details: Information
Publication Date: April 08, 2026
Newspapers: Business Standard, Pratahkal
Website Availability: https://solara.co.in/investor-relations/newspaper-publications
Previous Notice Date: April 07, 2026

Call Money Payment Requirements

Shareholders holding partly paid rights equity shares must pay ₹112.50 per share during the specified payment period. This amount comprises ₹3.00 towards face value and ₹109.50 towards securities premium, representing the final payment required to convert partly paid shares to fully paid equity shares.

Payment Schedule: Details
Call Amount: ₹112.50 per share
Face Value Component: ₹3.00
Premium Component: ₹109.50
Payment Period: April 23, 2026 to May 07, 2026
Duration: 15 days (both days inclusive)

Notice Dispatch Timeline

The company had earlier dispatched electronic notices on April 06, 2026, to shareholders whose email addresses are registered with the company, registrar Cameo Corporate Services Limited, or depository participants. Physical copies were dispatched on April 07, 2026, to shareholders without registered email addresses, with the record date set as April 02, 2026.

Payment Methods and Support

Multiple payment options are available to facilitate the call money payment process, including online ASBA through Self-Certified Syndicate Banks websites, physical ASBA by submitting application forms to designated SCSB branches, and 3-in-1 accounts using linked online trading-demat-bank accounts offered by brokers.

For queries and clarifications, shareholders can contact the registrar at +91 044 40020700/764/785/712 during business hours or email rights@cameoindia.com . The detailed instructions and ASBA application forms are available on the company's website and the registrar's portal at https://rights.cameoindia.com/solarsecondcall .

What will be the impact on Solara's share price and trading liquidity if a significant portion of shareholders fail to pay the final call money by May 07, 2026?

How does Solara plan to utilize the capital raised from this rights issue to expand its pharmaceutical operations or research capabilities?

Will the completion of this final call payment trigger any changes in Solara's credit ratings or debt refinancing strategies?

Solara Active Pharma Sciences Publishes Rights Share Call Advertisement

1 min read     Updated on 25 Mar 2026, 09:14 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Solara Active Pharma Sciences has published newspaper advertisements in Business Standard and Pratahkal on March 25, 2026, informing shareholders about the second and final call of ₹112.50 per rights share. The company set April 2, 2026, as the record date for determining eligible shareholders, with proper regulatory filings made to BSE and NSE under SEBI compliance requirements.

powered bylight_fuzz_icon
35874627

*this image is generated using AI for illustrative purposes only.

Rights Issue Committee Decision

Solara Active Pharma Sciences Limited has announced the publication of newspaper advertisements regarding the second and final call on partly-paid rights shares, following the Rights Issue Committee meeting held on March 24, 2026. The pharmaceutical company published advertisements in Business Standard and Pratahkal newspapers on March 25, 2026, informing shareholders about the call details and record date.

Call Amount Structure

The committee has determined a comprehensive call amount structure for the partly-paid rights shares:

Component: Amount per Share
Face Value: ₹3.00
Securities Premium: ₹109.50
Total Call Amount: ₹112.50

Record Date and Process Details

Key details of the rights share call process have been established:

Parameter: Details
Record Date: Thursday, April 2, 2026
Purpose: Determining holders of partly paid-up equity shares
Action: Call notices dispatch to eligible shareholders
Basis: Rights shares under May 9, 2024 Letter of Offer
Website Publication: https://solara.co.in/investor-relations/newspaper-publications

Stock Exchange Communication

The formal announcement was communicated to both major stock exchanges where the company's shares are listed:

Exchange: Details
BSE Limited: Scrip Code 541540, Symbol SOLARA
NSE India Limited: Scrip Code 890202, Symbol SOLARAPP1
Compliance: Regulation 30 and 42 of SEBI LODR 2015
Filing Date: March 25, 2026

Corporate Governance and Compliance

The intimation was signed by Pooja Jaya Kumar, Company Secretary and Compliance Officer (ICSI Membership No. A57415), ensuring adherence to corporate governance protocols. The communication included detailed regulatory disclosures as required under SEBI guidelines, with the newspaper advertisements being made available on the company's official website for investor reference.

Share Transfer Window Notice

The company has also announced a special window for re-lodgement of transfer requests for physical shares, running from February 5, 2026, to February 4, 2027. This facility is available for shareholders whose transfer requests were rejected or returned due to document deficiencies before March 31, 2021, in compliance with SEBI circular requirements.

How will the ₹112.50 per share call amount impact Solara's cash flow and capital structure once fully collected?

What strategic initiatives or expansion plans does Solara intend to fund with the capital raised from this rights issue completion?

Will the completion of this rights issue affect Solara's debt-to-equity ratio and overall financial leverage in the pharmaceutical sector?

More News on Solara Active Pharma Sciences - PP